CFD'er er komplekse instrumenter, og der er stor risiko for at miste penge hurtigt på grund af gearing. 84% af individuelle investorer taber penge, når de handler CFD'er med denne udbyder. Du bør overveje, om du forstår, hvordan CFD'er virker, og om du har råd til at løbe en høj risiko for at miste dine penge.
Capital Com Australia Pty Ltd Reguleret af ASIC Capital Com UK Limited Reguleret af Financial Conduct Authority (FCA) Capital Com SV Investments Limited Reguleret af CYSEC Сlosed Joint Stock Company «FinTech Solutions» Reguleret af NBRB Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Reguleret af FSA Capital Com Online Investments Ltd Reguleret af SCB Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Du kan også kontakte os: ring +44 2030978888 support@capital.com

Handel Edwards Lifesciences - EW CFD

80.85
0.29%
0.31
Lav: 80.48
Høj: 81.03
Market Trading Hours* (UTC) Open now
Closes on Monday at 20:00

Mon - Fri: 13:30 - 20:00

  • Opsummering
  • Historisk Data
  • Begivenheder
  • Resultatopgørelse
  • Saldo
  • Cash flow
  • Ejerskab
Handelsbetingelser
Spænd 0.31
Long position, gebyr natten over

Long position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
-0.024068%
Short position, gebyr natten over

Short position overnight fee

Margin. Your investment $1,000.00
Gebyr for natten over 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Gå til platform
0.001846%
Gebyr natten over, tid 21:00 (UTC)
Min. handlet mængde 1
Valuta USD
Margen 20%
Aktiebørs United States of America
Kommission på handel 0%

*Information provided by Capital.com

Edwards Lifesciences Corp ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

Nøglestatistikker
Tidligere luk* 80.64
Åben* 80.48
1-Års Ændring* -28.33%
Dagens Spænd* 80.48 - 81.03
52-Ugers Spænd 67.13-131.10
Gennemsnitlig Volumen (10 dage) 4.52M
Gennemsnitlig Volumen (3 måneder) 72.97M
Market Cap 49.12B
P/E-forhold 33.11
Udestående aktier 608.31M
Omsætning 5.38B
EPS 2.44
Dividend (Udbytte %) N/A
Beta 1.02
Næste indtjeningsopgørelse Apr 24, 2023

Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Luk Change Change (%) Åben High Low
Mar 17, 2023 80.60 -0.59 -0.73% 81.19 82.47 80.07
Mar 16, 2023 81.75 3.75 4.81% 78.00 82.14 77.86
Mar 15, 2023 79.38 2.90 3.79% 76.48 79.40 76.42
Mar 14, 2023 78.02 0.90 1.17% 77.12 78.15 76.27
Mar 13, 2023 76.49 3.17 4.32% 73.32 76.92 73.00
Mar 10, 2023 74.24 -1.46 -1.93% 75.70 75.78 73.78
Mar 9, 2023 75.94 -1.12 -1.45% 77.06 78.03 75.78
Mar 8, 2023 77.13 0.21 0.27% 76.92 77.33 75.83
Mar 7, 2023 78.81 0.39 0.50% 78.42 79.91 78.32
Mar 6, 2023 78.68 -1.99 -2.47% 80.67 81.19 78.41
Mar 3, 2023 81.76 0.83 1.03% 80.93 82.05 80.47
Mar 2, 2023 80.12 1.19 1.51% 78.93 80.72 78.83
Mar 1, 2023 79.77 0.08 0.10% 79.69 79.96 78.57
Feb 28, 2023 80.37 3.57 4.65% 76.80 80.88 76.80
Feb 27, 2023 77.21 0.80 1.05% 76.41 78.27 76.41
Feb 24, 2023 76.11 0.00 0.00% 76.11 77.08 75.74
Feb 23, 2023 77.46 2.13 2.83% 75.33 77.57 75.33
Feb 22, 2023 75.31 -0.21 -0.28% 75.52 76.45 75.24
Feb 21, 2023 75.45 -2.00 -2.58% 77.45 77.69 75.21
Feb 17, 2023 78.39 2.46 3.24% 75.93 78.46 75.93

Edwards Lifesciences Events

Tid (UTC) (UTC) Land Begivenhed
No events scheduled
Se alle begivenheder
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Total omsætning 2963.7 3435.3 3722.8 4348 4386.3 5232.5
Omsætning 2963.7 3435.3 3722.8 4348 4386.3 5232.5
Kost af omsætning, Total 797.4 875.3 939.4 1114.4 1080.6 1248.9
Bruttofortjeneste 2166.3 2560 2783.4 3233.6 3305.7 3983.6
Totale Driftsudgifter 2225.8 2400.4 2967.5 3201.2 3488.7 3542.2
Salgs/Generelle/Admin. Udgifter, Total 904.7 985.8 1088.5 1240.2 1228.4 1493.7
Forskning & Udvikling 443.3 552.6 622.2 752.7 760.7 903.1
Renteudgift (Indkomst) - Netto Drift 8.7 -1.6
Usædvanlig Udgift (Indkomst) 67.1 -13.4 323.1 100 405.4 20.6
Other Operating Expenses, Total 4.6 1.7 -5.7 -6.1 13.6 -124.1
Driftsindtægter 737.9 1034.9 755.3 1146.8 897.6 1690.3
Netto Indkomst Før Skat 737.9 1034.9 761.4 1166.5 916.7 1702
Netto Indkomst Efter Skat 569.5 877.7 738 1049.7 823.4 1503.1
Netto Indkomst Før Ekstra Ting 569.5 877.7 738 1049.7 823.4 1503.1
Netto Indkomst 569.5 583.6 722.2 1046.9 823.4 1503.1
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 569.5 877.7 738 1049.7 823.4 1503.1
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 569.5 583.6 722.2 1046.9 823.4 1503.1
Fortyndet Netto Indkomst 569.5 583.6 722.2 1046.9 823.4 1503.1
Fortyndet Vægtet Gennemsnit Aktier 653.407 647.706 640.806 636.606 631.9 631.2
Fortyndet EPS Uden Ekstraordinære Ting 0.87159 1.35509 1.15167 1.6489 1.30305 2.38134
Fortyndet Normaliseret EPS 0.95084 1.33754 1.64039 1.79025 1.87932 2.41016
Totale Ekstraordinære Ting -294.1 -15.8 -2.8
Renteindkomst (Udgift), Netto Ikke-Drift 17.3 21.3 20.5 9.8
Andre, Netto -11.2 -1.6 -1.4 1.9
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total omsætning 1216.6 1376 1310.2 1329.7 1341.2
Omsætning 1216.6 1376 1310.2 1329.7 1341.2
Kost af omsætning, Total 293.4 334.3 311.7 309.5 299.3
Bruttofortjeneste 923.2 1041.7 998.5 1020.2 1041.9
Totale Driftsudgifter 833.1 833.9 919.9 955.3 902.4
Salgs/Generelle/Admin. Udgifter, Total 330.8 374.5 364.4 424 370.3
Forskning & Udvikling 207 225.3 238 232.8 228.6
Usædvanlig Udgift (Indkomst) 6.4 2.4 4.7 7.1 7.1
Other Operating Expenses, Total -4.5 -102.6 1.1 -18.1 -2.9
Driftsindtægter 383.5 542.1 390.3 374.4 438.8
Renteindkomst (Udgift), Netto Ikke-Drift 4.7 3.1 0.4 1.6 -4
Andre, Netto 1.1 0.3 0.2 0.3 1.3
Netto Indkomst Før Skat 389.3 545.5 390.9 376.3 436.1
Netto Indkomst Efter Skat 338.2 489.5 340.1 335.3 373.6
Netto Indkomst Før Ekstra Ting 338.2 489.5 340.1 335.3 373.6
Netto Indkomst 338.2 489.5 340.1 335.3 373.6
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 338.2 489.5 340.1 335.3 373.6
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting 338.2 489.5 340.1 335.3 373.6
Fortyndet Netto Indkomst 338.2 489.5 340.1 335.3 373.6
Fortyndet Vægtet Gennemsnit Aktier 631.3 629.9 631.7 631.8 629.4
Fortyndet EPS Uden Ekstraordinære Ting 0.53572 0.77711 0.53839 0.53071 0.59358
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Fortyndet Normaliseret EPS 0.54453 0.78053 0.54486 0.54072 0.60325
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Totale Nuværende Aktiver 2240 2549.2 2286.9 2984 3091 3180.7
Likvider og Kortsigtede Investeringer 1271.1 1337.5 956.5 1516.9 1402.6 1466.8
Likvider & Lignende 930.1 818.3 714.1 1179.1 1183.2 862.8
Kortsigtede Investeringer 341 519.2 242.4 337.8 219.4 604
Totale Tilgodehavender, Netto 414.6 479.3 537.3 599.1 602.8 664.9
Accounts Receivable - Trade, Net 414.6 438.7 456.9 543.6 514.6 582.2
Total Inventory 396.6 554.9 607 640.9 802.3 726.7
Prepaid Expenses 45.9 60.6 54.3 59.1 75.1 85.2
Other Current Assets, Total 111.8 116.9 131.8 168 208.2 237.1
Total Assets 4510 5666.4 5323.7 6488.1 7237.1 8502.6
Property/Plant/Equipment, Total - Net 580 679.7 867.5 1140.4 1489.4 1638.7
Goodwill, Net 626.1 1126.5 1112.2 1167.7 1173.2 1167.9
Intangibles, Net 204.8 468 343.2 336.5 331.4 323.6
Long Term Investments 532.1 567 506.3 585.5 801.6 1834.2
Other Long Term Assets, Total 327 276 207.6 274 350.5 357.5
Total Current Liabilities 532.5 1420 876.6 902.4 893.9 1032.3
Accounts Payable 97.1 116.6 134 180.4 196.5 204.5
Accrued Expenses 418.4 516.1 510.2 642.7 578.7 714.2
Notes Payable/Short Term Debt 0 0 0 0 0 0
Other Current Liabilities, Total 17 189.3 232.4 79.3 118.7 113.6
Total Liabilities 1891 2710.2 2183.3 2339.8 2662.8 2666.7
Total Long Term Debt 822.3 438.4 593.8 594.4 595 595.7
Long Term Debt 822.3 438.4 593.8 594.4 595 595.7
Other Liabilities, Total 536.2 851.8 588 671.3 959.5 779.7
Total Equity 2619 2956.2 3140.4 4148.3 4574.3 5835.9
Preferred Stock - Non Redeemable, Net 0 0 0 0 0 0
Common Stock 242.6 212 215.2 218.1 636.4 642
Additional Paid-In Capital 1167.8 1166.9 1384.4 1623.3 1438.1 1700.4
Retained Earnings (Accumulated Deficit) 3906.3 1962.1 2694.7 3741.6 4565 6068.1
Treasury Stock - Common -2499.3 -252.1 -1015.4 -1278.7 -1904.1 -2416.9
Other Equity, Total -198.4 -128.1 -133.5 -157.7 -169.7 -150.8
Total Liabilities & Shareholders’ Equity 4510 5666.4 5323.7 6488.1 7237.1 8502.6
Total Common Shares Outstanding 634.806 629.106 623.106 627.306 624.3 624.1
Current Port. of LT Debt/Capital Leases 598 0 0 0
Unrealized Gain (Loss) -4.6 -5 1.7 8.6 -6.9
Property/Plant/Equipment, Total - Gross 1322.8 1652.7 2087.9 2293.3
Accumulated Depreciation, Total -455.3 -512.3 -598.5 -654.6
Deferred Income Tax 124.9 171.7 214.4 259
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Totale Nuværende Aktiver 3069.2 3322.9 3515.5 3180.7 3241.3
Likvider og Kortsigtede Investeringer 1330.6 1561.2 1794.7 1466.8 1495.9
Likvider & Lignende 1174.2 1312.8 1506.9 862.8 1030.9
Kortsigtede Investeringer 156.4 248.4 287.8 604 465
Totale Tilgodehavender, Netto 664.3 700.3 664.2 664.9 686.2
Accounts Receivable - Trade, Net 586.6 640.5 600.6 582.2 636.3
Total Inventory 767.9 759.5 737.8 726.7 730.6
Prepaid Expenses 77.3 68.6 76.9 85.2 94.1
Other Current Assets, Total 229.1 233.3 241.9 237.1 234.5
Total Assets 7213.7 7662.1 8160.3 8502.6 8419.9
Property/Plant/Equipment, Total - Net 1506.4 1530.4 1549.4 1638.7 1642.3
Goodwill, Net 1170.8 1171.8 1170.4 1167.9 1166.3
Intangibles, Net 330.3 327 325.3 323.6 322
Long Term Investments 802.2 1014.2 1282 1834.2 1623.7
Other Long Term Assets, Total 334.8 295.8 317.7 357.5 424.3
Total Current Liabilities 799 886.2 966.5 1032.3 949.9
Accounts Payable 150.4 144.6 139.5 204.5 158.8
Accrued Expenses 546.9 634.7 721.7 714.2 615.9
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 101.7 106.9 105.3 113.6 175.2
Total Liabilities 2555.3 2528.8 2619 2666.7 2575
Total Long Term Debt 595.2 595.4 595.5 595.7 595.9
Long Term Debt 595.2 595.4 595.5 595.7 595.9
Deferred Income Tax 224.2 234.2 245.4 259 270.7
Other Liabilities, Total 936.9 813 811.6 779.7 758.5
Total Equity 4658.4 5133.3 5541.3 5835.9 5844.9
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 637.5 640.1 641.2 642 642.9
Additional Paid-In Capital 1496.8 1578.7 1643.1 1700.4 1769.4
Retained Earnings (Accumulated Deficit) 4903.2 5392.7 5732.8 6068.1 6441.7
Treasury Stock - Common -2206.7 -2318.6 -2320.4 -2416.9 -2822.5
Unrealized Gain (Loss) 4.7 4.8 3 -6.9 -39.2
Other Equity, Total -177.1 -164.4 -158.4 -150.8 -147.4
Total Liabilities & Shareholders’ Equity 7213.7 7662.1 8160.3 8502.6 8419.9
Total Common Shares Outstanding 621.8 623.1 624.2 624.1 621.4
  • Årlig
  • Pr kvartal
2016 2017 2018 2019 2020 2021
Netto indkomst/Startlinje 569.5 583.6 722.2 1046.9 823.4 1503.1
Likvider Fra Driftsaktiviteter 704.4 1000.7 926.8 1179.4 1054.3 1732.1
Likvider Fra Driftsaktiviteter 71.2 81.9 77.4 89.3 107.2 134.8
Deferred Taxes -37.4 17.8 -27.3 12.1 -49.4 -41.4
Ikke-Likvide Ting 35 83.2 197.1 235.4 130.9 -9.7
Cash Taxes Paid 99.9 143.7 223.7 61.5 197.9 182.5
Likvid Rente Betalt 16.1 19.9 30.1 19.9 19.9 20.2
Ændringer i Driftskapital 66.1 234.2 -42.6 -204.3 42.2 145.3
Likvider fra Investeringsaktiviteter -211.7 -647.2 76.7 -595.8 -531.1 -1722.5
Kapitaludgifter -217.4 -175.5 -241.7 -278.4 -407.3 -329.8
Andre Investerings-Cash-Flow-Ting, Total 5.7 -471.7 318.4 -317.4 -123.8 -1392.7
Likvider fra Financieringsaktiviteter -268.5 -473.2 -1101.2 -115.6 -486.9 -356.3
Financiering af Cash-Flow-Ting 68.4 0 -15.4 -2.8 -1.2 -0.3
Udstedelse (Pensionering) af Aktier, Netto -559 -649.5 -648.5 -102.8 -484.9 -354.2
Udstedelse (Pensionering) af Gæld, Netto 222.1 176.3 -437.3 -10 -0.8 -1.8
Udenlandsk Børs Effekter -12.5 7.9 -6.5 -3 -20.5 13.9
Netto Ændring i Likviditet 211.7 -111.8 -104.2 465 15.8 -332.8
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line 338.2 827.7 1167.8 1503.1 373.6
Cash From Operating Activities 300.5 826.6 1358.5 1732.1 293.3
Cash From Operating Activities 32.4 68.2 101.8 134.8 34.7
Deferred Taxes 10.8 16.2 20.1 -41.4 -42.6
Non-Cash Items 28.3 -47.5 -15.8 -9.7 57
Changes in Working Capital -109.2 -38 84.6 145.3 -129.4
Cash From Investing Activities -49.7 -379.2 -756.6 -1722.5 229.5
Capital Expenditures -106 -175.3 -236 -329.8 -72.7
Other Investing Cash Flow Items, Total 56.3 -203.9 -520.6 -1392.7 302.2
Cash From Financing Activities -274.3 -333.3 -294.3 -356.3 -368.1
Financing Cash Flow Items -2.9 -3 -1 -0.3 0
Issuance (Retirement) of Stock, Net -271 -328.7 -291.6 -354.2 -368.1
Issuance (Retirement) of Debt, Net -0.4 -1.6 -1.7 -1.8 0
Foreign Exchange Effects 14.2 11.6 12.1 13.9 13.2
Net Change in Cash -9.3 125.7 319.7 -332.8 167.9
Investornavn Investortype Procent udestående Aktiebeholdning Aktieændring Beholdningsdato IOmsætningsscore
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 8.4282 51269903 639997 2022-12-31 LOW
BlackRock Institutional Trust Company, N.A. Investment Advisor 5.3695 32663343 1051645 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.488 27301166 493844 2022-12-31 LOW
Capital International Investors Investment Advisor 3.7385 22741986 44526 2022-12-31 LOW
AllianceBernstein L.P. Investment Advisor/Hedge Fund 3.6146 21988324 4770672 2022-12-31 LOW
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.5105 15271736 624619 2022-12-31 LOW
Brown Advisory Investment Advisor/Hedge Fund 2.3575 14341102 115268 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.9951 12136243 205714 2022-12-31 LOW
Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 1.811 11016774 -647534 2022-12-31 LOW
Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4506 8824423 2342600 2022-12-31 LOW
Fisher Investments Investment Advisor/Hedge Fund 1.2613 7672618 133880 2022-12-31 LOW
Sands Capital Management, LLC Investment Advisor 1.2356 7516085 -2889817 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 1.0808 6574509 4084454 2022-12-31 HIGH
BlackRock Asset Management Ireland Limited Investment Advisor 0.9468 5759351 129517 2022-12-31 LOW
Nuveen LLC Pension Fund 0.8833 5373020 -65227 2022-12-31 LOW
BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 0.7864 4783540 -652308 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.7454 4534155 2227180 2022-12-31 HIGH
Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.7446 4529198 -237259 2022-12-31 LOW
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.7156 4353305 8792 2022-12-31 LOW
American Century Investment Management, Inc. Investment Advisor/Hedge Fund 0.7115 4328367 473547 2022-12-31 LOW

Hvorfor vælge Capital.com? Vores tal taler for sig selv.

Capital.com Group
500000+

Handlende

92000+

Månedlkige, aktive klienter

$53000000+

Månedlig investeringsvolumen

$30000000+

Hævet hver måned

Handelslommeregner

Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).

Handelskurtage
0
  • 1:1
Gearing
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investering
Handelsstørrelse (Gearing x Investering):
Åben

Luk

Short Long
Tidligere resultater er ikke en pålidelig indikator for fremtidige resultater
Fortjeneste/Tab

Edwards Lifesciences Company profile

Om Edwards Lifesciences

Edwards Lifesciences Corporation er en producent af hjerteklapsystemer og reparationsprodukter, der anvendes til at erstatte eller reparere en patients syge eller defekte hjerteklap. Selskabet er involveret i patientfokuserede innovationer inden for strukturelle hjertesygdomme og overvågning af kritisk pleje. Virksomhedens segmenter omfatter USA, Europa, Japan og resten af verden. Selskabets produkter og teknologier er inddelt i fire hovedområder: Transkatheter udskiftning af aortaklapper, transkatheterbehandlinger af mitral- og trikuspidalklapper, kirurgisk strukturelt hjerte og kritisk pleje. Virksomheden udvikler også hæmodynamiske og ikke-invasive systemer til overvågning af hjerne og iltning af væv, der anvendes til at måle patientens kardiovaskulære funktion på hospitaler. Edwards SAPIEN-familien af klapper, herunder Edwards SAPIEN XT, Edwards SAPIEN 3 og Edwards SAPIEN 3 Ultra transkateter aortaklapper, anvendes til behandling af hjerteklapsygdomme.

Industry: Advanced Medical Equipment & Technology (NEC)

One Edwards Way
92614

Resultatopgørelse

  • Annual
  • Quarterly

Folk ser også

US100

12,517.20 Price
-0.170% 1D Chg, %
Long position, gebyr natten over -0.0241%
Short position, gebyr natten over 0.0018%
Gebyr natten over, tid 21:00 (UTC)
Spænd 1.8

Gold

1,970.96 Price
-0.680% 1D Chg, %
Long position, gebyr natten over -0.0167%
Short position, gebyr natten over 0.0084%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.30

Oil - Crude

66.26 Price
-0.830% 1D Chg, %
Long position, gebyr natten over -0.0200%
Short position, gebyr natten over -0.0019%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.03

XRP/USD

0.38 Price
-1.760% 1D Chg, %
Long position, gebyr natten over -0.0753%
Short position, gebyr natten over 0.0069%
Gebyr natten over, tid 21:00 (UTC)
Spænd 0.00334

Leder du stadig efter en mægler, du kan stole på?

Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com

1. Opret og bekræft din konto 2. Lav en inddbetaling 3. Find din handel